ATE270331T1 - Rezeptor und dafür kodierendes nukleinsäuremolekül - Google Patents

Rezeptor und dafür kodierendes nukleinsäuremolekül

Info

Publication number
ATE270331T1
ATE270331T1 AT96938867T AT96938867T ATE270331T1 AT E270331 T1 ATE270331 T1 AT E270331T1 AT 96938867 T AT96938867 T AT 96938867T AT 96938867 T AT96938867 T AT 96938867T AT E270331 T1 ATE270331 T1 AT E270331T1
Authority
AT
Austria
Prior art keywords
nucleic acid
receptor
acid molecule
molecule coding
amino acid
Prior art date
Application number
AT96938867T
Other languages
English (en)
Inventor
Didier Communi
Sabine Pirotton
Marc Parmentier
Jean-Marie Boeynaems
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of ATE270331T1 publication Critical patent/ATE270331T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT96938867T 1995-11-21 1996-11-21 Rezeptor und dafür kodierendes nukleinsäuremolekül ATE270331T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95870124 1995-11-21
PCT/BE1996/000123 WO1997019170A1 (en) 1995-11-21 1996-11-21 Receptor and nucleic acid molecule encoding said receptor

Publications (1)

Publication Number Publication Date
ATE270331T1 true ATE270331T1 (de) 2004-07-15

Family

ID=8222166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938867T ATE270331T1 (de) 1995-11-21 1996-11-21 Rezeptor und dafür kodierendes nukleinsäuremolekül

Country Status (8)

Country Link
US (5) US6790626B2 (de)
EP (2) EP0862628B1 (de)
JP (1) JP4439592B2 (de)
AT (1) ATE270331T1 (de)
CA (1) CA2235627C (de)
DE (1) DE69632830T2 (de)
DK (1) DK0862628T3 (de)
WO (1) WO1997019170A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235627C (en) * 1995-11-21 2010-08-10 Euroscreen S.A. Receptor and nucleic acid molecule encoding said receptor
EP1104465A1 (de) * 1998-08-20 2001-06-06 Millennium Pharmaceuticals, Inc. 14400 rezeptor, ein g-protein gekoppeltes rezeptor
SE9804175D0 (sv) * 1998-12-02 1998-12-02 Astra Pharma Prod New assay
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
EP1237909A2 (de) * 1999-11-16 2002-09-11 PHARMACIA & UPJOHN COMPANY Menschliche g-protein gekoppelte rezeptoren
WO2002000700A2 (en) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Regulation of human p2y8-like g protein-coupled receptor
MXPA03000165A (es) * 2000-07-07 2003-09-22 Univ North Carolina Metodo y sistema de ensayo para la identificacion de agonistas y antagonistas del receptor p2y.
WO2005101003A1 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with purinoceptor 4 type y (p2y4)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010538A1 (en) * 1993-10-15 1995-04-20 The University Of North Carolina At Chapel Hill Dna encoding the human p2u receptor and null cells expressing p2u receptors
US6008039A (en) 1995-06-02 1999-12-28 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel purinergic P2U receptor
CA2235627C (en) * 1995-11-21 2010-08-10 Euroscreen S.A. Receptor and nucleic acid molecule encoding said receptor

Also Published As

Publication number Publication date
US7312317B2 (en) 2007-12-25
EP0862628B1 (de) 2004-06-30
EP1452600A1 (de) 2004-09-01
CA2235627C (en) 2010-08-10
US20070044166A1 (en) 2007-02-22
US20040259171A1 (en) 2004-12-23
US20040175766A1 (en) 2004-09-09
US7270966B2 (en) 2007-09-18
JP2000503526A (ja) 2000-03-28
US20030082674A1 (en) 2003-05-01
EP0862628A1 (de) 1998-09-09
JP4439592B2 (ja) 2010-03-24
US6790626B2 (en) 2004-09-14
DK0862628T3 (da) 2004-11-01
DE69632830T2 (de) 2005-08-25
WO1997019170A1 (en) 1997-05-29
DE69632830D1 (de) 2004-08-05
CA2235627A1 (en) 1997-05-29
US20040268426A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
EP0977767A4 (de) Aminooxy-modifizierte oligonukleotide
DK1013661T3 (da) 2'-O,4'-metylen bicyklonukleosid
ATE232880T1 (de) Neue nucleotidanaloga
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
DE69627698D1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
ATE265465T1 (de) Stabilisierte oligonucleotide und deren verwendung
DE59510742D1 (de) Nukleoside und Oligonukleotide mit 2'-Ethergruppen
ATE277068T1 (de) 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind
IL145497A0 (en) L-ribo-lna analogues
WO2002086088A3 (en) Polymerases with charge-switch activity and methods of generating such polymerases
ATE321866T1 (de) Mutierte 5-enolpyruvylshikimat-3-phosphat synthase, für dieses protein kodierendes gen und dieses gen enthaltende transformierte pflanzen
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
DE69736840D1 (de) Synthese von nukleosiden und polynukleotiden
AU2299999A (en) Dnas or genes participating in parkinson's disease
ATE270331T1 (de) Rezeptor und dafür kodierendes nukleinsäuremolekül
DE69917636D1 (en) Polymerasesignalversuch
TR199902434T2 (xx) Bakteriyel plazmidler.
CY1106337T1 (el) Μια ακολουθια dna του ενζυμου φωσφολιπαση α1 απο ciliate tetrahymena και η χρησιμοποιηση του
ATE332981T1 (de) Einzelsträngige oligonukleotide, sonden, primer und ein vefahren zur detektion von spirochaeten
PT1384777E (pt) Adn genómicos que participam na artrite reumatóide, método de diagnóstico da mesma, método de estimativa dos seus riscos iniciais e kit de diagnóstico para a detecção da mesma
DE69726276D1 (de) In situ herstellung von nukleosid-phosphoramiditen und ihre verwendung in der oligonukleotidsynthese
NZ507993A (en) Human deadenylating nuclease, its preparation and use
MX9800339A (es) Preparacion in situ de nucleosido fosforamiditas y sintesis de oligonucleotido.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0862628

Country of ref document: EP

REN Ceased due to non-payment of the annual fee